Ovarian Hyperstimulation Syndrome: Clinical Trials

2 trials for Ovarian Hyperstimulation Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Ovarian Hyperstimulation Syndrome: new trials by email Literature Review of Ovarian Hyperstimulation Syndrome trials Research Report on Ovarian Hyperstimulation Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Administration of Methylprednisolone for Prevention of Ovarian Hyper Stimulation Syndrome
Methylprednisolone, Control - Ovarian Hyperstimulation Syndrome
Phase 1 / Phase 2CompletedRoyan Institute2182009-10-012011-07-15
Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program
Cabergoline, Control - Ovarian Hyperstimulation Syndrome
Phase 1 / Phase 2CompletedRoyan Institute102009-06-012015-05-06

Broader conditions

Adnexal Diseases (2)  ·  Endocrine System Diseases (2)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Gonadal Disorders (2)  ·  Ovarian Diseases (2)  ·  Urogenital Diseases (2)

Interventions

Cabergoline (1)  ·  Methylprednisolone (1)

Sponsors

Royan Institute (2)

Countries

Iran (2)

Top investigators

Ashraf Moini, MD (2)  ·  Marzieh Shiva, MD (2)  ·  Eniseh Tehraninejad, MD (1)

Results publications

PMID 22231013